期刊文献+

人SUMO-2基因原核表达、纯化及多克隆抗体制备 被引量:1

Prokaryotic expression,purification and preparation of polyclonal antibody for human SUMO-2 gene
下载PDF
导出
摘要 目的:构建人SUMO-2基因的原核表达载体,纯化融合蛋白GST-SUMO2-SUMO2并以其为抗原免疫家兔,制备人SUMO-2多克隆抗体。方法:用PCR的方法得到人SUMO-2基因并克隆至pET41a(+)原核表达载体中,转化大肠杆菌BL21(DE3)plysS诱导融合蛋白GST-SUMO2-SUMO2表达;所获得的可溶性蛋白经亲和层析纯化、SDS-PAGE电泳鉴定后,免疫家兔制备抗血清,分别采用ELISA、Western blot检测抗体效价和特异性。结果:测序证实重组质粒pET41a(+)-SU-MO2-SUMO2构建成功;SDS-PAGE结果证实获得Mr为52000的GST-SUMO2-SUMO2融合蛋白且为可溶性蛋白;经过GST亲和层析有效纯化;以该融合蛋白免疫家兔制备得到的抗血清经Western blot检测证实能与目的蛋白发生特异性结合,ELISA检测为阳性。结论:获得了人SUMO-2蛋白及特异性多克隆抗体,对进一步研究人SUMO-2及SUMO第二类家族的功能提供了有用工具。 AIM: To construct a prokaryotic expression vector of human SUMO-2, purify GST-SUMO2-SUMO2 fusion protein produced by the expression system, and prepare its antiserum. METHODS: The human SUMO-2 gene was amplified by PCR. The target fragment digested by the enzyme was cloned into a pET41a( + ) expression vector and then transfected into E. coli. BL21 (DE3) pLysS, in which GST-SUMO2-SUMO2 fusion protein was induced by IPTG. After the soluble protein was purified by GST affinity chromatography and by identified by SDS-PAGE, the rabbits were immunized with the fusion protein and the antiserum was obtained. RESULTS: DNA sequence analysis showed the cloned SUMO-2 gene sequence was completely corresponding to GenBank data. SDS-PAGE and Western blot showed that the GST-SUMO2-SUMO2 fusion protein was about 52 kDa, which was mainly the soluble protein of E. coil and could be purified by GST affinity chromatography. The result of ELISA was positive and Western blot confirmed the antiserum reacted specifically to SUMO-2 protein. CONCLUSION: SUMO-2 protein and its specific polyclonal antibody have been prepared, which provides a basis for the establishment of immunoassays of human SUMO-2.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第7期710-713,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 陕西省国际科技合作计划基金资助(2007KW-11)
关键词 人SUMO-2 原核表达 蛋白纯化 抗血清 human SUMO-2 prokaryotic expression protein purification antiserum
  • 相关文献

参考文献12

  • 1Verger A, Perdomo G, Crossley M. Modification with SUMO A role in transcriptional regulation [ J ]. Eur Mol Biol Org, 2003, 4 ( 2 ) : 137 - 142.
  • 2Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3[J]. J Biol Chem, 2000, 275(3) : 6252 -6258.
  • 3Tatham MH, Jaffray E. Vaughan OA, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9 [J]. J Biol Chem, 2001,276(2) : 35368 -35374.
  • 4Muller S, Hoege C, Pyrowolakis G, et al. SUMO, ubiquitin's mysterious consin[ J]. Nat Rev Mol Cell Biol, 2001,2(4) : 202 -203.
  • 5Hay RT. Protein modification by SUMO[J]. Curr Biol, 2003, 13 (5) : R258 - R259.
  • 6陈泉,施蕴渝.小泛素相关修饰物SUMO研究进展[J].生命科学,2004,16(1):1-6. 被引量:18
  • 7Gill G. SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? [J].Gene Dev, 2004, 18(2) : 2046 -2059.
  • 8叶晓峰,吴乔.类泛素蛋白——SUMO[J].细胞生物学杂志,2004,26(1):10-14. 被引量:12
  • 9Hilgarth RS, Murphy LA, Skaggs HS, et al. Regulation and function of SUMO modification[ J]. J Biol Chem, 2004, 279 (52): 53899 - 53902.
  • 10吕素芳,刘峥,郭广君,蔡永萍,邱德文.大肠杆菌中表达外源重组蛋白的研究[J].科学技术与工程,2006,6(18):2872-2876. 被引量:14

二级参考文献66

共引文献36

同被引文献9

  • 1宋振,王劼,安宁,杨振,雷鸣,郭泽坤.人SUMO-1基因原核表达、纯化及多克隆抗体制备与鉴定[J].免疫学杂志,2009,25(2):125-129. 被引量:5
  • 2Hofmann TG, Will H. Body language: the function of PML nuclear bodies in apoptosis regulation[ J]. Cell Death Differ, 2003, 10(12) : 1290 - 1299.
  • 3Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif[ J ]. Oncogene, 2001,20 (49) : 7223 - 7233.
  • 4Zhong S, Salomoni P, Pandolfi PP. The transcriptional role of PML and the nuclear body[J]. Nat Cell Biol, 2000, 2(5) : E85 -90.
  • 5Ficarro SB, MeCleland ML, Stukenberg PT, et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae [ J ]. Nature Biotechnology, 2002, 20 ( 3 ) : 301 - 305.
  • 6Krupa A, Preethi G, Srinivasan N. Structural modes of stabilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases[ J]. J Mol Biol, 2004, 339(5) : 1025 - 1039.
  • 7Idriss HT. Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer[J]. Cancer Chemother Pharmacol, 2004, 54(2) : 101 -104.
  • 8Reineke EL, Kao HY. Targeting promyelocytic leukemia protein: A means to regulating PML nuclear bodies[ J ]. Int J Biol Sci, 2009, 5 (4) : 366 -376.
  • 9Zhong S, Muller S, Ronchetti S, et al. Role of SUMO-1-modified PML in nuclear body formation [ J ]. Blood, 2000, 95 (9) : 2748 - 2752.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部